{
    "Allele Frequency": "0.065", 
    "Build 37 Chromosome": "chr11", 
    "Build 37 Position": "116662407", 
    "Build 37 Variant Allele": "C", 
    "Build37 coordinates:": [], 
    "Clinical Importance": "Low", 
    "Condition Tags": [
        "Heart and circulatory", 
        "Metabolism"
    ], 
    "Evidence": "Likely", 
    "Gene Symbol": "APOA5", 
    "Impact": "Pathogenic", 
    "Inheritance": "Unknown", 
    "PMID Count": 5, 
    "PMID List": [
        "12417524", 
        "12417525", 
        "16143024", 
        "16682041", 
        "19802338"
    ], 
    "Scores": {
        "Case/Control": "4", 
        "Computational": "2", 
        "Familial": "0", 
        "Functional": "0", 
        "Penetrance": "2", 
        "Severity": "3", 
        "Treatability": "3"
    }, 
    "Summary": "This variant, also known as APOA5*3, is associated with higher plasma triglyceride concentrations but no significant correlation with coronary artery disease itself has been found.", 
    "URL": "http://evidence.pgp-hms.org/APOA5-S19W", 
    "Variant Name": "APOA5-S19W", 
    "Variant Page": "http://evidence.pgp-hms.org/APOA5-S19W", 
    "dbSNP IDs": [
        "rs3135506"
    ]
}